PTC Therapeutics, Inc. Insider Transactions
PTC Therapeutics, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Gravier Pierre
CHIEF FINANCIAL OFFICER |
Sell | 2,269 @ $34.02 | $77,200 | 53,531 | 07/16/2024 | 07/18/2024 | |
ZELDIS JEROME B
Director |
Sell | 20,000 @ $38.24 | $764,800 | 14,500 | 05/22/2024 | 05/24/2024 | |
Golden Lee Scott
EVP & CHIEF MEDICAL OFFICER |
Sell | 175 @ $32.82 | $5,744 | 59,813 | 05/07/2024 | 05/08/2024 | |
Klein Matthew B.
Director, CHIEF EXECUTIVE OFFICER |
Sell | 3,361 @ $24.89 | $83,669 | 225,807 | 04/19/2024 | 04/22/2024 | |
Pauwels Eric
Director, CHIEF EXECUTIVE OFFICER |
Sell | 787 @ $25.14 | $19,781 | 67,694 | 04/17/2024 | 04/19/2024 | |
Klein Matthew B.
Director, CHIEF EXECUTIVE OFFICER |
Sell | 1,307 @ $25.14 | $32,851 | 229,168 | 04/17/2024 | 04/19/2024 | |
Golden Lee Scott
EVP & CHIEF MEDICAL OFFICER |
Sell | 526 @ $28.37 | $14,923 | 59,988 | 04/02/2024 | 04/04/2024 | |
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 618 @ $27.25 | $16,841 | 61,202 | 01/30/2024 | 02/01/2024 | |
Utter Christine Marie
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 318 @ $27.25 | $8,666 | 35,528 | 01/30/2024 | 02/01/2024 | |
Boulding Mark Elliott
EXEC. VP AND CLO |
Sell | 794 @ $27.25 | $21,637 | 71,189 | 01/30/2024 | 02/01/2024 | |
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 28 @ $27.25 | $763 | 3,706 | 01/30/2024 | 02/01/2024 | |
Pauwels Eric
CHIEF BUSINESS OFFICER |
Sell | 366 @ $27.25 | $9,974 | 44,181 | 01/30/2024 | 02/01/2024 | |
Jacobson Allan Steven
Director |
Sell | 10,000 @ $27.38 | $273,804 | 12,348 | 01/22/2024 | 01/24/2024 | |
Klein Matthew B.
Director, CHIEF EXECUTIVE OFFICER |
Sell | 5,443 @ $29.01 | $157,928 | 160,475 | 01/09/2024 | 01/10/2024 | |
Golden Lee Scott
CHIEF MEDICAL OFFICER |
Sell | 1,225 @ $29.01 | $35,543 | 37,914 | 01/09/2024 | 01/10/2024 | |
Boulding Mark Elliott
EXEC. VP AND CLO |
Sell | 1,938 @ $29.01 | $56,231 | 71,983 | 01/09/2024 | 01/10/2024 | |
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 1,521 @ $29.01 | $44,132 | 61,820 | 01/09/2024 | 01/10/2024 | |
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 100 @ $29.01 | $2,901 | 3,734 | 01/09/2024 | 01/10/2024 | |
Utter Christine Marie
SVP, FINANCE & CAO |
Sell | 1,653 @ $29.01 | $47,961 | 35,846 | 01/09/2024 | 01/10/2024 | |
Pauwels Eric
CHIEF BUSINESS OFFICER |
Sell | 2,065 @ $29.01 | $59,916 | 44,547 | 01/09/2024 | 01/10/2024 |
PTC Therapeutics, Inc. FAQ's
The list of insiders at PTC Therapeutics, Inc. includes Jacobson Allan Steven, Pauwels Eric, Almstead Neil Gregory, Utter Christine Marie, Boulding Mark Elliott, Golden Lee Scott, Klein Matthew B., ZELDIS JEROME B, Gravier Pierre.
Insiders have sold a total of 40,549 PTC Therapeutics, Inc. shares in the last 12 months for a total of 1.33 M sold.
The following insiders have sold PTC Therapeutics, Inc. shares in the last 12 months: Jacobson Allan Steven ($273,804), Pauwels Eric ($29,755), Almstead Neil Gregory ($17,604), Utter Christine Marie ($8,666), Boulding Mark Elliott ($21,637), Golden Lee Scott ($20,666), Klein Matthew B. ($116,520), ZELDIS JEROME B ($764,800), Gravier Pierre ($77,200),